Newsroom

Newsroom

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

Press Release
Read More

Efficient Large Scale Cell Classification and Analysis for MultiOmyx™ Assays: A Deep Learning Approach

Literature
Read More

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Literature
Read More

Tumor-Infiltrating Myeloid Cells – Using MultiOmyx™ to Distinguish between TAMs, TANs, and MDSCs in the Pancreatic Tumor Microenvironment

Literature
Read More

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification

Literature
Read More

NeoGenomics Announces Executive Appointments

Press Release
Read More

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

Press Release
Read More

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients